Vitamins and minerals: Efficacy and safety

被引:117
作者
Hathcock, JN
机构
[1] Council for Responsible Nutrition, Washington, DC 20036-1609
关键词
vitamins; minerals; benefits; efficacy; safety; adverse effects;
D O I
10.1093/ajcn/66.2.427
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Safety and efficacy are crucial but separate issues for vitamin and mineral supplements. Misinterpretation of ''safe and adequate'' to mean ''safety limit'' would impose restrictions on vitamin and mineral intakes that are not needed to ensure safety. Substantial evidence indicates that intakes greater than the recommended dietary allowances (RDAs) of certain vitamins and minerals such as calcium, folic acid, vitamin E, selenium, and chromium reduce the risk of certain diseases for some people. Limitation of intakes to the RDAs would preclude reductions in disease risk from these nutrients. The margin of safety between the usual dietary intake and the intake that would produce adverse effects varies greatly among the different nutrients. Very high intakes of vitamins A and D, niacin, pyridoxine, and selenium have produced adverse effects. Many widely discussed putative adverse effects of vitamin C, vitamin E, and trivalent chromium have little factual basis. There is no evidence of adverse effects from beta-carotene supplements except in current heavy smokers.
引用
收藏
页码:427 / 437
页数:11
相关论文
共 152 条
  • [1] LIAROZOLE POTENTIATES THE CANCER CHEMOPREVENTIVE ACTIVITY OF AND THE UP-REGULATION OF GAP JUNCTIONAL COMMUNICATION AND CONNEXIN43 EXPRESSION BY RETINOIC ACID AND BETA-CAROTENE IN 10T1/2 CELLS
    ACEVEDO, P
    BERTRAM, JS
    [J]. CARCINOGENESIS, 1995, 16 (09) : 2215 - 2222
  • [2] alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance
    Albanes, D
    Heinonen, OP
    Taylor, PR
    Virtamo, J
    Edwards, BK
    Rautalahti, M
    Hartman, AM
    Palmgren, J
    Freedman, LS
    Haapakoski, J
    Barrett, MJ
    Pietinen, P
    Malila, N
    Tala, E
    Liippo, K
    Salomaa, ER
    Tangrea, JA
    Teppo, L
    Askin, FB
    Taskinen, E
    Erozan, Y
    Greenwald, P
    Huttunen, JK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) : 1560 - 1570
  • [3] LONG-TERM FOLLOW-UP OF PYRIDOXINE-INDUCED ACUTE SENSORY NEUROPATHY-NEURONOPATHY
    ALBIN, RL
    ALBERS, JW
    [J]. NEUROLOGY, 1990, 40 (08) : 1319 - 1319
  • [4] ACUTE SENSORY NEUROPATHY-NEURONOPATHY FROM PYRIDOXINE OVERDOSE
    ALBIN, RL
    ALBERS, JW
    GREENBERG, HS
    TOWNSEND, JB
    LYNN, RB
    BURKE, JM
    ALESSI, AG
    [J]. NEUROLOGY, 1987, 37 (11) : 1729 - 1732
  • [5] ALHADEFF L, 1984, NUTR REV, V42, P33, DOI 10.1111/j.1753-4887.1984.tb02278.x
  • [6] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
  • [7] [Anonymous], 1994, NIH Consens Statement, V12, P1
  • [8] [Anonymous], 1994, Natural antioxidants in human health and disease
  • [9] [Anonymous], 1983, SEL NUTR
  • [10] [Anonymous], 1988, SURG GEN REP NUTR HL